Results of Voting for Directors at Annual and Special Shareholders' Meeting
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, May 11, 2023 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation HFPC ("HFP") announces the results of the vote on directors at the Annual and Special Meeting of Shareholders held on May 11, 2023.
All of the nominees listed in HFP's management proxy circular dated March 22, 2023 were elected as directors of the Company. The voting results are set forth in the table below:
| Name of Nominee | Vote For (Aggregate) | Percentage |
Vote Against (Aggregate) |
Percentage |
| Kofi Adjepong-Boateng | 2,799,481,211 | 100.0 | 43,700 | 0.0 |
| Ken Costa | 2,799,480,511 | 100.0 | 44,400 | 0.0 |
| Lt. Gen. (ret.) Roméo Dallaire | 2,799,495,147 | 100.0 | 29,764 | 0.0 |
| Christopher D. Hodgson | 2,799,496,911 | 100.0 | 28,000 | 0.0 |
| Tope Lawani | 2,799,482,011 | 100.0 | 42,900 | 0.0 |
| Quinn McLean | 2,799,481,911 | 100.0 | 43,000 | 0.0 |
| Sahar Nasr | 2,799,496,111 | 100.0 | 28,800 | 0.0 |
| Babatunde Soyoye | 2,799,497,311 | 100.0 | 27,600 | 0.0 |
| Masai Ujiri | 2,799,481,311 | 100.0 | 43,600 | 0.0 |
Helios Fairfax Partners Corporation is an investment holding company whose investment objective is to achieve long term capital appreciation, while preserving capital, by investing in public and private equity securities and debt instruments in Africa and African businesses or other businesses with customers, suppliers or business primarily conducted in, or dependent on, Africa.
For further information, contact:
| Julia Gray General Counsel & Corporate Secretary (647) 243-9882 |
Neil Weber Investor Relations LodeRock Advisors (647) 222-0574 neil.weber@loderockadvisors.com www.loderockadvisors.com |
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
